The purpose of this study is to evaluate the efficacy and tolerability of prednisone in patients diagnosed with ocular myasthenia. This trial is currently recruiting participants.
Sponsor: Michael Benatar
Link: https://clinicaltrials.gov/ct2/show/NCT00995722Year Trial Ends: 2018